Selected research
Industry Research
HPV Therapeutic Vaccines Industry Research Report 2026
Market perspective
The global HPV Therapeutic Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the HPV Therapeutic Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the HPV Therapeutic Vaccines market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the HPV Therapeutic Vaccines market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of HPV Therapeutic Vaccines include Shanghai Bovax Biotechnology Co., Ltd., Sanofi Pasteur, Johnson and Johnson., Pfizer, GlaxoSmithKline plc, Wantai BioPharm, Serum Institute, Profectus BioSciences, Inc. and Merck & Co., Inc, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global HPV Therapeutic Vaccines market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to HPV Therapeutic Vaccines.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
HPV Therapeutic Vaccines Market by Company
Shanghai Bovax Biotechnology Co., Ltd.
Sanofi Pasteur
Johnson and Johnson.
Pfizer
GlaxoSmithKline plc
Wantai BioPharm
Serum Institute
Profectus BioSciences, Inc.
Merck & Co., Inc
ISA Pharmaceuticals
INOVIO Pharmaceuticals
Emergent BioSolutions
Astellas Pharma
2A Pharma AB
HPV Therapeutic Vaccines Segment by Type
Bivalent HPV vaccine
Quadrivalent HPV vaccine
HPV Therapeutic Vaccines Segment by Application
Man
Woman
HPV Therapeutic Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HPV Therapeutic Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of HPV Therapeutic Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HPV Therapeutic Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of HPV Therapeutic Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bivalent HPV vaccine
- Quadrivalent HPV vaccine
Applications
- Man
- Woman
Companies covered
- Shanghai Bovax Biotechnology Co., Ltd.
- Sanofi Pasteur
- Johnson and Johnson.
- Pfizer
- GlaxoSmithKline plc
- Wantai BioPharm
- Serum Institute
- Profectus BioSciences, Inc.
- Merck & Co., Inc
- ISA Pharmaceuticals
- INOVIO Pharmaceuticals
- Emergent BioSolutions
- Astellas Pharma
- 2A Pharma AB
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 HPV Therapeutic Vaccines by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Bivalent HPV vaccine
- 2.2.3 Quadrivalent HPV vaccine
- 2.3 HPV Therapeutic Vaccines by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Man
- 2.3.3 Woman
- 2.4 Assumptions and Limitations
3 HPV Therapeutic Vaccines Breakdown Data by Type
- 3.1 Global HPV Therapeutic Vaccines Historic Market Size by Type (2021-2026)
- 3.2 Global HPV Therapeutic Vaccines Forecasted Market Size by Type (2027-2032)
4 HPV Therapeutic Vaccines Breakdown Data by Application
- 4.1 Global HPV Therapeutic Vaccines Historic Market Size by Application (2021-2026)
- 4.2 Global HPV Therapeutic Vaccines Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global HPV Therapeutic Vaccines Market Perspective (2021-2032)
- 5.2 Global HPV Therapeutic Vaccines Growth Trends by Region
- 5.2.1 Global HPV Therapeutic Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 HPV Therapeutic Vaccines Historic Market Size by Region (2021-2026)
- 5.2.3 HPV Therapeutic Vaccines Forecasted Market Size by Region (2027-2032)
- 5.3 HPV Therapeutic Vaccines Market Dynamics
- 5.3.1 HPV Therapeutic Vaccines Industry Trends
- 5.3.2 HPV Therapeutic Vaccines Market Drivers
- 5.3.3 HPV Therapeutic Vaccines Market Challenges
- 5.3.4 HPV Therapeutic Vaccines Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top HPV Therapeutic Vaccines Players by Revenue
- 6.1.1 Global Top HPV Therapeutic Vaccines Players by Revenue (2021-2026)
- 6.1.2 Global HPV Therapeutic Vaccines Revenue Market Share by Players (2021-2026)
- 6.2 Global HPV Therapeutic Vaccines Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of HPV Therapeutic Vaccines Head Office and Area Served
- 6.4 Global HPV Therapeutic Vaccines Players, Product Type & Application
- 6.5 Global HPV Therapeutic Vaccines Manufacturers Established Date
- 6.6 Global HPV Therapeutic Vaccines Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America HPV Therapeutic Vaccines Market Size (2021-2032)
- 7.2 North America HPV Therapeutic Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America HPV Therapeutic Vaccines Market Size by Country (2021-2026)
- 7.4 North America HPV Therapeutic Vaccines Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe HPV Therapeutic Vaccines Market Size (2021-2032)
- 8.2 Europe HPV Therapeutic Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe HPV Therapeutic Vaccines Market Size by Country (2021-2026)
- 8.4 Europe HPV Therapeutic Vaccines Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific HPV Therapeutic Vaccines Market Size (2021-2032)
- 9.2 Asia-Pacific HPV Therapeutic Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific HPV Therapeutic Vaccines Market Size by Country (2021-2026)
- 9.4 Asia-Pacific HPV Therapeutic Vaccines Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America HPV Therapeutic Vaccines Market Size (2021-2032)
- 10.2 South America HPV Therapeutic Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America HPV Therapeutic Vaccines Market Size by Country (2021-2026)
- 10.4 South America HPV Therapeutic Vaccines Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa HPV Therapeutic Vaccines Market Size (2021-2032)
- 11.2 Middle East & Africa HPV Therapeutic Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2021-2026)
- 11.4 Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Shanghai Bovax Biotechnology Co., Ltd.
- 12.1.1 Shanghai Bovax Biotechnology Co., Ltd. Company Information
- 12.1.2 Shanghai Bovax Biotechnology Co., Ltd. Business Overview
- 12.1.3 Shanghai Bovax Biotechnology Co., Ltd. Revenue in HPV Therapeutic Vaccines Business (2021-2026)
- 12.1.4 Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Product Portfolio
- 12.1.5 Shanghai Bovax Biotechnology Co., Ltd. Recent Developments
- 12.2 Sanofi Pasteur
- 12.2.1 Sanofi Pasteur Company Information
- 12.2.2 Sanofi Pasteur Business Overview
- 12.2.3 Sanofi Pasteur Revenue in HPV Therapeutic Vaccines Business (2021-2026)
- 12.2.4 Sanofi Pasteur HPV Therapeutic Vaccines Product Portfolio
- 12.2.5 Sanofi Pasteur Recent Developments
- 12.3 Johnson and Johnson.
- 12.3.1 Johnson and Johnson. Company Information
- 12.3.2 Johnson and Johnson. Business Overview
- 12.3.3 Johnson and Johnson. Revenue in HPV Therapeutic Vaccines Business (2021-2026)
- 12.3.4 Johnson and Johnson. HPV Therapeutic Vaccines Product Portfolio
- 12.3.5 Johnson and Johnson. Recent Developments
- 12.4 Pfizer
- 12.4.1 Pfizer Company Information
- 12.4.2 Pfizer Business Overview
- 12.4.3 Pfizer Revenue in HPV Therapeutic Vaccines Business (2021-2026)
- 12.4.4 Pfizer HPV Therapeutic Vaccines Product Portfolio
- 12.4.5 Pfizer Recent Developments
- 12.5 GlaxoSmithKline plc
- 12.5.1 GlaxoSmithKline plc Company Information
- 12.5.2 GlaxoSmithKline plc Business Overview
- 12.5.3 GlaxoSmithKline plc Revenue in HPV Therapeutic Vaccines Business (2021-2026)
- 12.5.4 GlaxoSmithKline plc HPV Therapeutic Vaccines Product Portfolio
- 12.5.5 GlaxoSmithKline plc Recent Developments
- 12.6 Wantai BioPharm
- 12.6.1 Wantai BioPharm Company Information
- 12.6.2 Wantai BioPharm Business Overview
- 12.6.3 Wantai BioPharm Revenue in HPV Therapeutic Vaccines Business (2021-2026)
- 12.6.4 Wantai BioPharm HPV Therapeutic Vaccines Product Portfolio
- 12.6.5 Wantai BioPharm Recent Developments
- 12.7 Serum Institute
- 12.7.1 Serum Institute Company Information
- 12.7.2 Serum Institute Business Overview
- 12.7.3 Serum Institute Revenue in HPV Therapeutic Vaccines Business (2021-2026)
- 12.7.4 Serum Institute HPV Therapeutic Vaccines Product Portfolio
- 12.7.5 Serum Institute Recent Developments
- 12.8 Profectus BioSciences, Inc.
- 12.8.1 Profectus BioSciences, Inc. Company Information
- 12.8.2 Profectus BioSciences, Inc. Business Overview
- 12.8.3 Profectus BioSciences, Inc. Revenue in HPV Therapeutic Vaccines Business (2021-2026)
- 12.8.4 Profectus BioSciences, Inc. HPV Therapeutic Vaccines Product Portfolio
- 12.8.5 Profectus BioSciences, Inc. Recent Developments
- 12.9 Merck & Co., Inc
- 12.9.1 Merck & Co., Inc Company Information
- 12.9.2 Merck & Co., Inc Business Overview
- 12.9.3 Merck & Co., Inc Revenue in HPV Therapeutic Vaccines Business (2021-2026)
- 12.9.4 Merck & Co., Inc HPV Therapeutic Vaccines Product Portfolio
- 12.9.5 Merck & Co., Inc Recent Developments
- 12.10 ISA Pharmaceuticals
- 12.10.1 ISA Pharmaceuticals Company Information
- 12.10.2 ISA Pharmaceuticals Business Overview
- 12.10.3 ISA Pharmaceuticals Revenue in HPV Therapeutic Vaccines Business (2021-2026)
- 12.10.4 ISA Pharmaceuticals HPV Therapeutic Vaccines Product Portfolio
- 12.10.5 ISA Pharmaceuticals Recent Developments
- 12.11 INOVIO Pharmaceuticals
- 12.11.1 INOVIO Pharmaceuticals Company Information
- 12.11.2 INOVIO Pharmaceuticals Business Overview
- 12.11.3 INOVIO Pharmaceuticals Revenue in HPV Therapeutic Vaccines Business (2021-2026)
- 12.11.4 INOVIO Pharmaceuticals HPV Therapeutic Vaccines Product Portfolio
- 12.11.5 INOVIO Pharmaceuticals Recent Developments
- 12.12 Emergent BioSolutions
- 12.12.1 Emergent BioSolutions Company Information
- 12.12.2 Emergent BioSolutions Business Overview
- 12.12.3 Emergent BioSolutions Revenue in HPV Therapeutic Vaccines Business (2021-2026)
- 12.12.4 Emergent BioSolutions HPV Therapeutic Vaccines Product Portfolio
- 12.12.5 Emergent BioSolutions Recent Developments
- 12.13 Astellas Pharma
- 12.13.1 Astellas Pharma Company Information
- 12.13.2 Astellas Pharma Business Overview
- 12.13.3 Astellas Pharma Revenue in HPV Therapeutic Vaccines Business (2021-2026)
- 12.13.4 Astellas Pharma HPV Therapeutic Vaccines Product Portfolio
- 12.13.5 Astellas Pharma Recent Developments
- 12.14 2A Pharma AB
- 12.14.1 2A Pharma AB Company Information
- 12.14.2 2A Pharma AB Business Overview
- 12.14.3 2A Pharma AB Revenue in HPV Therapeutic Vaccines Business (2021-2026)
- 12.14.4 2A Pharma AB HPV Therapeutic Vaccines Product Portfolio
- 12.14.5 2A Pharma AB Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst